|
MDAH
|
24188 nM
|
cell proliferation assays
|
PMC12254336
|
|
OVSAHO
|
19771 nM
|
cell proliferation assays
|
PMC12254336
|
|
SKOV3
|
39073 nM
|
cell proliferation assays
|
PMC12254336
|
|
JHOC5
|
21287 nM
|
cell proliferation assays
|
PMC12254336
|
|
PEO1
|
20406 nM
|
cell proliferation assays
|
PMC12254336
|
|
OVCAR7
|
40834 nM
|
cell proliferation assays
|
PMC12254336
|
|
COV362
|
20132 nM
|
cell proliferation assays
|
PMC12254336
|
|
MDAH Cis Res
|
16912 nM
|
cell proliferation assays
|
PMC12254336
|
|
OVSAHO Cis Res
|
24039 nM
|
cell proliferation assays
|
PMC12254336
|
|
PEO4
|
39254 nM
|
cell proliferation assays
|
PMC12254336
|
|
ABTR#2
|
22202 nM
|
cell proliferation assays
|
PMC12254336
|
|
Cov362-OlapR
|
37033 nM
|
cell proliferation assays
|
PMC12254336
|
|
HeLa cells
|
27.53 ±2.04 µM
|
MTT assay, half-maximal inhibitory concentration (IC50) values determined using a fitted curve generated by GraphPad Prism software version 9.
|
PMC12395164
|
|
L929 cells
|
94.36 ±5.02 µM
|
MTT assay, half-maximal inhibitory concentration (IC50) values determined using a fitted curve generated by GraphPad Prism software version 9.
|
PMC12395164
|
|
mononuclear cells (MNC) isolated from the patient bone marrow
|
2.00 μM
|
High throughput drug screening (HTS) with Z-score analysis of AUC and IC50
|
Download PDF
|
|
SLE-PBMCs
|
45.5 nmol/L
|
Assessed as described previously (30)
|
Download PDF
|
|
UCB-Tregs
|
33.4 nmol/L
|
Assessed as described previously (30)
|
Download PDF
|
|
human basophils
|
13.60 ± 3.93 mM
|
Log concentration-inhibition curve for mediator release (histamine) by plotting log concentration of ruxolitinib against percent inhibition of release, with IC50 values assessed by interpolation.
|
Download PDF
|
|
human basophils
|
13.20 ± 2.58 mM
|
Log concentration-inhibition curve for mediator release (IL-4) by plotting log concentration of ruxolitinib against percent inhibition of release, with IC50 values assessed by interpolation.
|
Download PDF
|
|
human basophils
|
21.60 ± 4.47 mM
|
Log concentration-inhibition curve for mediator release (IL-13) by plotting log concentration of ruxolitinib against percent inhibition of release, with IC50 values assessed by interpolation.
|
Download PDF
|
|
Nalm-6 cells
|
47.7 μM
|
CCK8 assay, calculated with GraphPad Prism
|
PMC10326758
|
|
Ba/F3 cells (JAK2V617F mutant)
|
80-320 nM
|
JAK-STAT signaling and cell proliferation assays
|
Download PDF
|
|
STAT inhibition (ex-vivo)
|
254 nM
|
STAT inhibition assay
|
PMC10064968
|
|
LX-2 cells
|
14.01 μM
|
Cell Counting Assay Kit-8 (CCK-8)
|
Download PDF
|
|
HT-22 cells
|
4 µM
|
Cell Counting Kit (CCK)-8 cytotoxicity assay
|
Download PDF
|
|
MUTZ5
|
15.17 µmol/L
|
Cell-Titer Glo viability assays
|
PMC8448976
|
|
MHH-cALL-4
|
27.01 µmol/L
|
Cell-Titer Glo viability assays
|
PMC8448976
|
|
JAK2 V617F KI bone marrow cells
|
25+/-1 nM
|
clonogenic assay
|
Download PDF
|
|
JAK2 wt bone marrow cells
|
>=150 nM
|
clonogenic assay
|
Download PDF
|
|
T-PLL cells (pretreatment)
|
3.85 × 10−8 M
|
CyQuant assay
|
PMC6072266
|
|
primary human hepatocytes
|
50 nM
|
dose-dependent effect on STAT3 phosphorylation
|
Download PDF
|
|
BaF3 cells expressing CSF3R-T618I
|
0.05 μM
|
Cell proliferation analysis (dose-response sigmoidal curve)
|
PMC5537052
|
|
BaF3 cells expressing CSF3R-Q741*
|
0.02 μM
|
Cell proliferation analysis (dose-response sigmoidal curve)
|
PMC5537052
|
|
BaF3 cells expressing CSF3R-W791*
|
0.02 μM
|
Cell proliferation analysis (dose-response sigmoidal curve)
|
PMC5537052
|
|
BaF3 cells expressing CSF3R-T618I/Q741*
|
0.5 μM
|
Cell proliferation analysis (dose-response sigmoidal curve)
|
PMC5537052
|
|
BaF3 cells expressing CSF3R-T618I/W791*
|
0.5 μM
|
Cell proliferation analysis (dose-response sigmoidal curve)
|
PMC5537052
|
|
TpoR JAK2 WT
|
4.2 µM
|
Cell viability assay (ATP levels measured with luciferase assay kit)
|
Download PDF
|
|
TpoR JAK2 V617F
|
1.6 µM
|
Cell viability assay (ATP levels measured with luciferase assay kit)
|
Download PDF
|
|
TpoR W515L
|
0.1 µM
|
Cell viability assay (ATP levels measured with luciferase assay kit)
|
Download PDF
|
|
Bcr-Abl
|
45.3 µM
|
Cell viability assay (ATP levels measured with luciferase assay kit)
|
Download PDF
|
|
JAK2 WT
|
1.0 µM
|
Cell viability assay (ATP levels measured with luciferase assay kit)
|
Download PDF
|
|
JAK2 V617F
|
0.4 µM
|
Cell viability assay (ATP levels measured with luciferase assay kit)
|
Download PDF
|